Intellia Therapeutics Inc buy Chardan Capital
Start price
28.02.25
/
50%
€9.69
Target price
28.02.26
€65.29
Performance (%)
13.42%
End price
01.03.26
€10.99
Summary
This prediction ended on 01.03.26 with a price of €10.99. The prediction had a final performance of 13.42%. Chardan_Capital has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -0.404% | -0.404% | 69.185% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Chardan Capital from $91.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
54.61%
16:02
16:02
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.72
27.02.26
27.02.26
€22.04
27.02.27
27.02.27
0.26%
16:02
16:02
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-4.55%
16:02
16:02
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24